Home      Login


Xylazine Wounds Are a Growing Crisis Among Drug Users—A Nurse Explains Potential Causes and Proper Treatment  


Author:  Rachel McFadden.


Source: Volume 25, Number 04, Fall 2024 , pp.77-78(2)




Correctional Health Care Report

< previous article |next article > |return to table of contents

Abstract: 

Xylazine or “tranq” wounds—characterized by deep pockets of dead tissue—have become increasingly visible in Philadelphia among people who use drugs. That’s because xylazine, an animal tranquilizer with no FDA-approved use in humans, is now pervasive in Philadelphia’s street fentanyl supply. Forensic testing has revealed xylazine’s presence in over 90% of street heroin and fentanyl samples, and Pennsylvania is considered the epicenter of the xylazine crisis. Rachel McFadden is an emergency room nurse at the Hospital of the University of Pennsylvania and also works at a wound care clinic in Kensington in North Philadelphia that serves people who use drugs. In this article, McFadden answers frequently asked questions about how to treat xylazine wounds and how the stigma around them prevents people from getting medical care and other help. This article is being made available at no charge.

Keywords: Xylazine; Tranq”; Wound Care

Affiliations:  1: University of Pennsylvania’s Emergency Department.

Subscribers click here to open full text in PDF.
Non-subscribers click here to purchase this article. $0

< previous article |next article > |return to table of contents